Thursday, January 22, 2026
ADVT 
International

'Taliban will be a threat to Central Asia and the world'

Darpan News Desk IANS, 27 Aug, 2021 10:35 AM
  • 'Taliban will be a threat to Central Asia and the world'

The Taliban militants that have captured Kabul and most of Afghanistan "will be a threat to Central Asia and the world", a senior member of the Panjshir Valley-based National Resistance Front of Afghanistan (NRF) told The Moscow Times.

"Russia should be concerned about the rise of the Taliban. The country will become a terrorist hub that will endanger Central Asia and Russia itself," Fahim Dashty told The Moscow Times by phone from the Panjshir Valley, where his resistance group has gathered as the country's last holdout against the Taliban.

The Panjshir region is famous for having successfully fought off invasions by Soviet forces in the Soviet-Afghan war from 1979-1989 as well as by the Taliban in the 1990s.

The NRF is currently led by Ahmad Massoud, the son of Ahmad Shah Massoud, a powerful guerrilla commander who led the resistance against the former Soviet Union.

Dashty was a close ally of Ahmad Shah Massoud, who was assassinated in a suicide bombing instigated by Al Qaeda and the Taliban on September 9, 2001, an attack in which he was also injured.

He now acts as spokesperson for the slain commander's son.

On Wednesday, Russia's Defence Minister Sergei Shoigu said the greatest threat posed by the Taliban was the "enormous" amount of arms the groups had captured as American troops hastily exited the country.

"The first and major threat is that the Taliban received an enormous amount of weapons. Enormous," Shoigu said, adding that he believed the Islamists now had hundreds of armoured vehicles, aircraft and helicopters.

MORE International ARTICLES

FDA approves first COVID-19 drug: antiviral remdesivir

FDA approves first COVID-19 drug: antiviral remdesivir
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

FDA approves first COVID-19 drug: antiviral remdesivir

Here we go again: Trump, Biden reprise debate duel

Here we go again: Trump, Biden reprise debate duel
Instead, they're bracing for another show of vintage Trump, one in which he'll seek to be heard even in spite of his muted microphone.

Here we go again: Trump, Biden reprise debate duel

Getting ready for the gong show: Trump v. Biden II

Getting ready for the gong show: Trump v. Biden II
It's the sequel to last month's debate horror show between Donald Trump and Joe Biden, an invective-laced 90 minutes that laid bare the depths to which political discourse can sink in an American election year.

Getting ready for the gong show: Trump v. Biden II

US overdose deaths appear to rise amid coronavirus pandemic

US overdose deaths appear to rise amid coronavirus pandemic
Davidson lost his job. He started staying home alone in his apartment near Georgetown, Kentucky — depressed and yearning for his recovery support group that had stopped gathering in person, said his cousin Melanie Wyatt.

US overdose deaths appear to rise amid coronavirus pandemic

Pfizer: Mid-November earliest it can seek virus vaccine OK

Pfizer: Mid-November earliest it can seek virus vaccine OK
Another leading U.S. contender, Moderna Inc., previously announced the earliest it could seek authorization of its own vaccine would be Nov. 25.

Pfizer: Mid-November earliest it can seek virus vaccine OK

UN: Europe's pandemic restrictions are absolutely necessary

UN: Europe's pandemic restrictions are absolutely necessary
In a meda briefing on Thursday, Dr. Hans Kluge warned that even more drastic steps might be needed in such “unprecedented times.”

UN: Europe's pandemic restrictions are absolutely necessary